AI-based digital pathology revealed that efruxifermin had an additional impact on septa area as well as fibrosis in a post hoc analysis of the SYMMETRY study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ai-pathology-shows-efruxifermin-benefits-mash-cirrhosis-2025a1000viw?src=rss
Author :
Publish date : 2025-11-13 11:27:00
Copyright for syndicated content belongs to the linked Source.